Art

J-GLOBAL ID：201402258004440500   Reference number：14A0890541

Clinical practice guidelines for therapeutic drug monitoring of arbekacin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

アルベカシンの薬物治療モニタリングのための診療ガイドライン 日本化学療法学会と日本TDM学会のコンセンサスレビュー

Author (36)： OKADA Kenji (Tokyo Women’s Medical Univ. Hospital, JPN) ,  OKADA Kenji (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  KIMURA Toshimi (Tokyo Women’s Medical Univ. Hospital, JPN) ,  KIMURA Toshimi (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  MIKAMO Hiroshige (Aichi Medical Univ., JPN) ,  MIKAMO Hiroshige (Japanese Soc. Chemotherapy, JPN) ,  KASAHARA Kei (Nara Medical Univ., JPN) ,  KASAHARA Kei (Japanese Soc. Chemotherapy, JPN) ,  SEKI Masafumi (Osaka Univ. Medical Hospital, JPN) ,  SEKI Masafumi (Japanese Soc. Chemotherapy, JPN) ,  TAKAKURA Shunji (Kyoto Univ. Hospital, JPN) ,  TAKAKURA Shunji (Japanese Soc. Chemotherapy, JPN) ,  TOKIMATSU Issei (Oita Univ. Fac. Medicine, JPN) ,  TOKIMATSU Issei (Japanese Soc. Chemotherapy, JPN) ,  OHMAGARI Norio (National Center for Global Health and Medicine Hospital, JPN) ,  OHMAGARI Norio (Japanese Soc. Chemotherapy, JPN) ,  TAKAHASHI Yoshiko (Hyogo Medical Coll. Hospital, JPN) ,  TAKAHASHI Yoshiko (Japanese Soc. Chemotherapy, JPN) ,  MATSUMOTO Kazuaki (Kagoshima Univ., JPN) ,  MATSUMOTO Kazuaki (Japanese Soc. Chemotherapy, JPN) ,  IGARASHI Masahiro (Toranomon Hospital, JPN) ,  IGARASHI Masahiro (Japanese Soc. Chemotherapy, JPN) ,  KOBAYASHI Masahiro (Kitasato Univ. Hospital, JPN) ,  KOBAYASHI Masahiro (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  HAMADA Yukihiro (Aichi Medical Univ., JPN) ,  HAMADA Yukihiro (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  MOCHIZUKI Takahiro (Shizuoka Cancer Center, JPN) ,  MOCHIZUKI Takahiro (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  KIMURA Masao (Aichi Medical Univ. Hospital, JPN) ,  KIMURA Masao (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  NISHI Yoshifumi (Kyorin Univ. School of Medicine, JPN) ,  NISHI Yoshifumi (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  TANIGAWA Yusuke (Keio Univ., JPN) ,  TANIGAWA Yusuke (Japanese Soc. Therapeutic Drug Monitoring, JPN) ,  TAKESUE Yoshio (Hyogo Medical Coll. Hospital, JPN) ,  TAKESUE Yoshio (Japanese Soc. Chemotherapy, JPN)
Material： Journal of Infection and Chemotherapy  (J Infect Chemother)
Volume： 20  Issue： 1-2  Page： 1-5  Publication year： Jan. 2014 
JST Material Number： L2852A  ISSN： 1341-321X  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *therapeutic drug monitoring ,...
Semi thesaurus term： guideline

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0890541&from=J-GLOBAL&jstjournalNo=L2852A") }}

JST classification (2)： Clinical application of antibiotics acting on pathogenic organisms  (GX05030N) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (1)： Arbekacin

Reference (29)：

• Kondo S, Iinuma K, Yamamoto H, Maeda K, Umezawa H. Syntheses of 1-n-((S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3',4'-dideoxykanamycin B active against kanamycin-resistant bacteria. J Antibiot 1973;26:412-5.
• Aoki Y. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Jpn J Antibiot 1994;47:640-6.
• Hamilton-Miller JM, Shah S. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1995;35:865-8.
• Sato R, Tanigawara Y, Kaku M, Aikawa N, Shimizu K. Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:3763-9.
• Begg EJ, Barclay ML, Kirkpatrick CM. The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol 2001;52(Suppl. 1):35S-43S.

Terms in the title (8)： アルベカシン ,  薬物治療モニタリング ,  診療ガイドライン ,  日本 ,  TDM ,  学会 ,  コンセンサス ,  レビュー